← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 2, 1999First marketed drug
Apr 19, 1940First NDA
Apr 19, 1940Last known activity
Oct 10, 2022
Timeline
1880s
- Jan 1, 1888
G D Searle— Founded
1940s
- Apr 19, 1940
aminophylline— NDA Secondary Org
- Apr 19, 1940
aminophylline— NDA Organization
1970s
- Apr 24, 1970
ethinyl estradiol— Marketing Organization
- Sep 7, 1973
Will Ross, Inc.— Acquired
1980s
- Jan 1, 1985
Monsanto— Acquired By
2000s
- Apr 16, 2003
Pfizer— Now
Drugs by trial phase (7 distinct, 7 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Approved for
- Acute Pain
- Adenomatous Polyposis Coli
- Adrenal Gland Diseases
- Alopecia
- Arrhythmias, Cardiac
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Asthma
- Dysmenorrhea
- Endometriosis
- Gender Dysphoria
- Gout
- Heart Failure
- Hemorrhage
- Hypertension
- Myocardial Infarction
- Nephrotic Syndrome
- Osteoarthritis
- Pain
- Puberty, Precocious
- Spondylitis, Ankylosing
- Stomach Ulcer
Marketed drugs (30)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (7)
- NCT06437080CollaboratorN/AOct 10, 2022
- NCT04689919CollaboratorPhase 1Feb 28, 2021
- NCT04938856CollaboratorPhase 1Sep 4, 2020
- NCT00000692Lead sponsorPhase 1Nov 2, 1999
- NCT00001993Lead sponsorPhase 2Nov 2, 1999
- NCT00002079Lead sponsorPhase 2Nov 2, 1999
- NCT00000791CollaboratorPhase 2Nov 2, 1999
Details
- Founded
- Omaha, NE, US Jan 1, 1888
- First NDA
- Apr 19, 1940
- Last known activity
- Oct 10, 2022
Designations held
- Orphan drug
- Priority review